Casey Woodring
Stock Analyst at JP Morgan
(1.63)
# 3,430
Out of 5,090 analysts
51
Total ratings
31.03%
Success rate
-9.61%
Average return
Main Sectors:
Stocks Rated by Casey Woodring
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BLLN BillionToOne | Initiates: Overweight | $150 | $111.64 | +34.36% | 1 | Dec 1, 2025 | |
| NTRA Natera | Maintains: Overweight | $240 → $250 | $244.55 | +2.23% | 2 | Nov 25, 2025 | |
| A Agilent Technologies | Maintains: Overweight | $165 → $180 | $145.49 | +23.72% | 2 | Nov 25, 2025 | |
| QDEL QuidelOrtho | Maintains: Underweight | $26 → $22 | $27.76 | -20.75% | 5 | Nov 7, 2025 | |
| TXG 10x Genomics | Maintains: Neutral | $13 → $15 | $17.77 | -15.59% | 1 | Nov 7, 2025 | |
| CRL Charles River Laboratories International | Maintains: Neutral | $160 → $165 | $184.31 | -10.48% | 9 | Nov 6, 2025 | |
| SHC Sotera Health Company | Maintains: Neutral | $14 → $16 | $16.75 | -4.48% | 3 | Nov 5, 2025 | |
| ILMN Illumina | Maintains: Neutral | $100 → $105 | $128.96 | -18.58% | 1 | Oct 31, 2025 | |
| AVTR Avantor | Downgrades: Neutral | $14 → $12 | $10.93 | +9.79% | 1 | Oct 30, 2025 | |
| IQV IQVIA Holdings | Maintains: Overweight | $177 → $255 | $225.85 | +12.91% | 1 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $78 | $74.97 | +4.04% | 6 | Oct 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $300 → $325 | $394.81 | -17.68% | 1 | Oct 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $600 → $650 | $572.77 | +13.48% | 1 | Oct 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $1,200 → $1,285 | $1,414.86 | -9.18% | 1 | Oct 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $60 → $70 | $102.02 | -31.39% | 1 | Sep 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $265 → $150 | $185.80 | -19.27% | 6 | Apr 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $54 → $56 | $47.01 | +18.32% | 4 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $7 → $6 | $2.49 | +141.45% | 3 | May 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $25 → $23 | $20.98 | +9.63% | 2 | Oct 31, 2023 |
BillionToOne
Dec 1, 2025
Initiates: Overweight
Price Target: $150
Current: $111.64
Upside: +34.36%
Natera
Nov 25, 2025
Maintains: Overweight
Price Target: $240 → $250
Current: $244.55
Upside: +2.23%
Agilent Technologies
Nov 25, 2025
Maintains: Overweight
Price Target: $165 → $180
Current: $145.49
Upside: +23.72%
QuidelOrtho
Nov 7, 2025
Maintains: Underweight
Price Target: $26 → $22
Current: $27.76
Upside: -20.75%
10x Genomics
Nov 7, 2025
Maintains: Neutral
Price Target: $13 → $15
Current: $17.77
Upside: -15.59%
Charles River Laboratories International
Nov 6, 2025
Maintains: Neutral
Price Target: $160 → $165
Current: $184.31
Upside: -10.48%
Sotera Health Company
Nov 5, 2025
Maintains: Neutral
Price Target: $14 → $16
Current: $16.75
Upside: -4.48%
Illumina
Oct 31, 2025
Maintains: Neutral
Price Target: $100 → $105
Current: $128.96
Upside: -18.58%
Avantor
Oct 30, 2025
Downgrades: Neutral
Price Target: $14 → $12
Current: $10.93
Upside: +9.79%
IQVIA Holdings
Oct 29, 2025
Maintains: Overweight
Price Target: $177 → $255
Current: $225.85
Upside: +12.91%
Oct 22, 2025
Downgrades: Neutral
Price Target: $78
Current: $74.97
Upside: +4.04%
Oct 9, 2025
Maintains: Neutral
Price Target: $300 → $325
Current: $394.81
Upside: -17.68%
Oct 9, 2025
Maintains: Overweight
Price Target: $600 → $650
Current: $572.77
Upside: +13.48%
Oct 9, 2025
Maintains: Neutral
Price Target: $1,200 → $1,285
Current: $1,414.86
Upside: -9.18%
Sep 25, 2025
Maintains: Overweight
Price Target: $60 → $70
Current: $102.02
Upside: -31.39%
Apr 29, 2025
Downgrades: Neutral
Price Target: $265 → $150
Current: $185.80
Upside: -19.27%
Jun 18, 2024
Maintains: Overweight
Price Target: $54 → $56
Current: $47.01
Upside: +18.32%
May 13, 2024
Maintains: Neutral
Price Target: $7 → $6
Current: $2.49
Upside: +141.45%
Oct 31, 2023
Maintains: Neutral
Price Target: $25 → $23
Current: $20.98
Upside: +9.63%